Your email has been successfully added to our mailing list.

×
0.00757575757575758 -0.0189393939393939 -0.034090909090909 -0.0795454545454545 -0.0871212121212121 -0.121212121212121 -0.106060606060606 -0.138257575757576
Stock impact report

FDA Grants Hoth Therapeutics Pre-IND Meeting Regarding Proposed Drug Development Plan for HT-001 Treatment for Cancer Patients

Hoth Therapeutics, Inc. (HOTH)  More Company Research Source: PR Newswire
Impact snapshot Event time: HOTH
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
HOTH alerts

from News Quantified
Opt-in for
HOTH alerts

from News Quantified